Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 24 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Routine hepatitis A childhood vaccination highly effective preventative measure

A project that offered free hepatitis A vaccination to children was highly effective in preventing the disease among recipients, according to an article in the latest issue of the Journal of the American Medical Association.

News image

fiogf49gjkf04

The project also appears to have decreased the incidence of hepatitis A among both children and adults and controlled the disease in a community with recurrent epidemics.

Francisco Averhoff, of the Centers for Disease Control and Prevention (CDC), Atlanta, and colleagues conducted a community-based demonstration project from 12 January 1995 through 31 December 2000, in Butte County, California.

Butte County had recurrent outbreaks of hepatitis A between 1985 and 1994.

The 1994 rate was highest among children younger than the age of 15 (193.0 per 100,000 population).

For the Butte County project, vaccination was offered to children aged 2 to 12, during vaccination clinics conducted at most schools in the county in 1995. This was done on two occasions, 6 to 12 months apart.

Between 1996 and 2000, vaccine was distributed to community health care clinicians who vaccinated eligible children without charge.

Vaccine was also available at health department clinics, selected childcare centers, and other sites.

During the study period, 29,789 (66.2%) of an estimated 44,982 eligible children received at least one vaccine dose; 17,681 (39.3%) received a second dose.

"The number of hepatitis A cases among the entire county population declined 93.5% during the study period, from 57 cases in 1995 to 4 in 2000.

"This is the lowest number of cases reported in the county since hepatitis A surveillance began in 1966," the authors report.

"The 2000 incidence rate of 1.9 per 100,000 population was the lowest of any county in the state.

Number of hepatitis A cases declined 94% between 1995 and 2000.
Journal of the American Medical Association

"Of the 245 cases reported during the 6-year period, 40 (16.3%) occurred among children 17 years of age or younger, of which 16 (40%) occurred in 1995 and only 1 in 2000," they write.

"One of the 27 case patients eligible for vaccination had been vaccinated, having received the first dose 3 days before symptom onset."

"The estimated protective vaccine efficacy was 98%," the authors report.

No serious adverse events were reported among the vaccine recipients, supporting the safety of hepatitis A vaccination.

"This 6-year project demonstrated the feasibility and effectiveness of routine childhood hepatitis A vaccination and its impact on community-wide rates of disease," the authors assert.

"The decline appears to be sustained; only 2 cases were reported to the CDC during the first half of 2001," they report, citing unpublished CDC data.

"The Butte County experience suggests that, over time, routine vaccination of children can reduce overall disease rates in the community.

"This previews the potential impact of routine childhood hepatitis A vaccination, as recently recommended by the Advisory Committee on Immunization Practices for areas of the United States with consistently high hepatitis A infection rates," the authors conclude.

JAMA 2001; 286: 2968-73
19 December 2001

Go to top of page Email this page Email this page to a colleague

 24 November 2017 
Osteoporotic fractures in Barrett's esophagus
 24 November 2017 
Center ERCP volume and procedure success
 24 November 2017 
Adipokines and IBD
 23 November 2017 
Pharmacological management of GERD
 23 November 2017 
Incidence of biopsy-verified celiac disease
 23 November 2017 
Distance travelling for rectal cancer outcomes
 22 November 2017 
Challenges of US-trained gastroenterologists when abroad
 22 November 2017 
Surgical treatment delays influence survival in colon cancer
 22 November 2017 
Golimumab in Crohn's disease
 21 November 2017 
Preoperative optimization in IBD patients
 21 November 2017 
Cholangiopathy in critically ill patients
 21 November 2017 
Prepregnancy obesity and maternal mortality
 20 November 2017 
Barriers to hepatitis C treatment
 20 November 2017 
Socioeconomic characteristics in diverticular disease
 20 November 2017 
Endoscopic indices of disease activity for Crohn’s
 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 15 November 2017 
Medication nonadherence and health care costs
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Autoimmune pancreatitis in children
 01 November 2017 
Heartburn relief in adolescents with GERD
 31 October 2017 
Follow-up of positive results on fecal blood tests
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us